A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1.
Tassopoulos NC, Tsantoulas D, Raptopoulou M, Vassiliadis T, Kanatakis S, Paraskevas E, Vafiadis I, Avgerinos A, Tzathas C, Manolakopoulos S, Ketikoglou I, Aggelis P, Goritsas K, Giannoulis G, Hatzis G G, Thomopoulos K, Akriviadis E, Sypsa V, Hatzakis A.
Tassopoulos NC, et al. Among authors: tsantoulas d.
J Viral Hepat. 2003 May;10(3):189-96. doi: 10.1046/j.1365-2893.2003.00406.x.
J Viral Hepat. 2003.
PMID: 12753337
Clinical Trial.